This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).

No content found

Data pager
Data pager
12
 Item 1 to 99 of 175
of 2 
Show all 175
Data pager
Data pager
12
 Item 1 to 99 of 175
of 2 
Show all 175
Sunday, June 16 | 4:00PM - 8:00PM
Arrival and Registration
Room: Longs Peak Foyer


Sunday, June 16 | 6:00PM - 8:00PM
Welcome Mixer
Room: Longs Peak Foyer
No registration fees are used to fund alcohol served at this function.

Monday, June 17 | 7:30AM - 8:30AM
Breakfast
Room: Colorado Rockies Ballroom


Monday, June 17 | 8:30AM - 9:30AM
Welcome and Keynote Address
Room: Grays/Longs Peak

Speaker 1 of 2
* Fred H. Gage, The Salk Institute for Biological Studies, USA

Monday, June 17 | 8:30AM - 9:30AM
Welcome and Keynote Address
Room: Grays/Longs Peak

Speaker 2 of 2
Marc Tessier-Lavigne, Stanford University, USA
Molecular Control of Axon Degeneration in Development, Disease and Adult Plasticity

Monday, June 17 | 9:30AM - 11:45AM
Aggregation Mediated Toxicity
Room: Grays/Longs Peak

Speaker 1 of 6
* Xiaobo Mao, Johns Hopkins University, USA

Monday, June 17 | 9:30AM - 11:45AM
Aggregation Mediated Toxicity
Room: Grays/Longs Peak

Speaker 2 of 6
Rudolph E. Tanzi, Massachusetts General Hospital, USA
Amyloid Beta Organoid Model

Monday, June 17 | 9:30AM - 11:45AM
Aggregation Mediated Toxicity
Room: Grays/Longs Peak


Coffee Break

Monday, June 17 | 9:30AM - 11:45AM
Aggregation Mediated Toxicity
Room: Grays/Longs Peak

Speaker 4 of 6
Valina L. Dawson, Johns Hopkins University School of Medicine, USA
Alpha Synuclein Toxicity

Monday, June 17 | 9:30AM - 11:45AM
Aggregation Mediated Toxicity
Room: Grays/Longs Peak

Speaker 5 of 6
Patrik Verstreken, KU Leuven, Belgium
Tau Toxicity at the Synapse

Monday, June 17 | 9:30AM - 11:45AM
Aggregation Mediated Toxicity
Room: Grays/Longs Peak

Speaker 6 of 6
Thomas Brannstrom, Umea University Hospital, Sweden
Short Talk: Transmissibility of SOD1 Prion Strains Between Mice Expressing Different Mutant Human SOD1s

Monday, June 17 | 9:30AM - 12:00PM
Neuronal Response to Injury
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 1 of 6
* David M. Holtzman, Washington University, USA
TREM2 Function Regulates Aß linked Tau Seeding and Spreading in Neuritic Plaques


Monday, June 17 | 9:30AM - 12:00PM
Neuronal Response to Injury
This session is from Neuroinflammation
Room: Quandary Peak


Coffee Break


Monday, June 17 | 9:30AM - 12:00PM
Neuronal Response to Injury
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 3 of 6
Eric J. Huang, University of California, San Francisco, USA
Neuron-Glia Interaction in Human Germinal Matrix: Implications in Neurodevelopmental Disorders


Monday, June 17 | 9:30AM - 12:00PM
Neuronal Response to Injury
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 4 of 6
* Marc R. Freeman, Oregon Health & Science University, USA
Mechanisms of Axon Degeneration


Monday, June 17 | 9:30AM - 12:00PM
Neuronal Response to Injury
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 5 of 6
Katie Ennis, Biogen, USA
Short Talk: The Cytokine Receptor Fn14 is Required for Hippocampal Synaptic Plasticity Deficits that Occur Following Acute Ischemic Stroke


Monday, June 17 | 9:30AM - 12:00PM
Neuronal Response to Injury
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 6 of 6
Lucas Cheadle, Harvard Medical School, USA
Short Talk: Sensory Experience Engages Microglia-to-Neuron Cytokine Signaling to Remodel Developing Synapses


Monday, June 17 | 11:45AM - 5:00PM
On Own for Lunch


Monday, June 17 | 11:45AM - 1:00PM
Poster Setup
Room: Colorado Rockies Ballroom


Monday, June 17 | 1:00PM - 10:00PM
Poster Viewing
Room: Colorado Rockies Ballroom


Monday, June 17 | 2:30PM - 4:30PM
Workshop 1: Modulating Microglia Inflammatory Signaling
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 1 of 10
* Kim N. Green, University of California, Irvine, USA


Monday, June 17 | 2:30PM - 4:30PM
Workshop 1: Modulating Microglia Inflammatory Signaling
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 2 of 10
* Iben Lundgaard, University of Lund, Sweden


Monday, June 17 | 2:30PM - 4:30PM
Workshop 1: Modulating Microglia Inflammatory Signaling
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 3 of 10
Ying Cao, Peking University, China
Transcriptional Mechanism of IRF8 and PU.1 Governs Microglial Activation in Neurodegenerative Condition


Monday, June 17 | 2:30PM - 4:30PM
Workshop 1: Modulating Microglia Inflammatory Signaling
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 4 of 10
Rouven Schulz, Institute of Science and Technology Austria, Austria
Topological Classification of Microglia


Monday, June 17 | 2:30PM - 4:30PM
Workshop 1: Modulating Microglia Inflammatory Signaling
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 5 of 10
Yajing Xu, University College London, UK
Microglia Mediate Restructuring of Spinal Somatosensory Circuits During Normal Postnatal Development and After Injury


Monday, June 17 | 2:30PM - 4:30PM
Workshop 1: Modulating Microglia Inflammatory Signaling
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 6 of 10
Youtong Huang, University of California, San Diego / Salk Institute, USA
Investigating Microglial TAM Receptors as Modulators of Alzheimer’s Pathology


Monday, June 17 | 2:30PM - 4:30PM
Workshop 1: Modulating Microglia Inflammatory Signaling
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 7 of 10
Guy C. Brown, University of Cambridge, UK
Blocking the Microglial P2Y6 Receptor Prevents Microglial Phagocytosis of Neurons and Synapses, and Prevents Neurodegeneration Induced by Neuroinflammation, Beta Amyloid, TAU and Ageing in vivo


Monday, June 17 | 2:30PM - 4:30PM
Workshop 1: Modulating Microglia Inflammatory Signaling
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 8 of 10
Monique S. Mendes, University of Rochester, USA
In vivo Imaging of Microglial Self-Renewal and Maturation in the Adult Mouse Brain


Monday, June 17 | 2:30PM - 4:30PM
Workshop 1: Modulating Microglia Inflammatory Signaling
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 9 of 10
Nicole Vo, University of Washington, USA
CD33 and CD45 interaction in AD


Monday, June 17 | 2:30PM - 4:30PM
Workshop 1: Modulating Microglia Inflammatory Signaling
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 10 of 10
Sanda Mimouna, Hospital for Special Surgery, USA
The Role of Transcriptional Coregulator GRIP1 in Myeloid Cells in Neuroinflammation


Monday, June 17 | 3:00PM - 4:30PM
Workshop 1
Room: Grays/Longs Peak

Speaker 1 of 7
* David V. Hansen, Genentech, Inc., USA

Monday, June 17 | 3:00PM - 4:30PM
Workshop 1
Room: Grays/Longs Peak

Speaker 2 of 7
Michael Henderson, University of Pennsylvania, USA
Using Quantitative Pathology Mapping and Network Modeling to Understand a-Synuclein Spread

Monday, June 17 | 3:00PM - 4:30PM
Workshop 1
Room: Grays/Longs Peak

Speaker 3 of 7
Sang Su Kwak, Genetics and Aging Research Unit, Massachusetts General Hospital, USA
Amyloid-ß 42/40 Ratio Drives Tau Pathology in 3D Human Neural Cell Culture Models of Alzheimer's Disease

Monday, June 17 | 3:00PM - 4:30PM
Workshop 1
Room: Grays/Longs Peak

Speaker 4 of 7
Evan T. Lester, University of Colorado, USA
Interactions between RNA and Tau in Models of Frontotemporal Dementia

Monday, June 17 | 3:00PM - 4:30PM
Workshop 1
Room: Grays/Longs Peak

Speaker 5 of 7
Sílvia Porta, Center for Neurodegenerative Disease Research, USA
Patient-Derived Frontotemporal Lobar Degeneration Brain Extracts Induce Formation and Spreading of TDP-43 Pathology in vivo

Monday, June 17 | 3:00PM - 4:30PM
Workshop 1
Room: Grays/Longs Peak

Speaker 6 of 7
Stephanie K. See, University of California, San Francisco, USA
Identification of Cellular Mechanisms that Control a-Synuclein Aggregation Using a CRISPRi/a Functional Genomics Platform

Monday, June 17 | 3:00PM - 4:30PM
Workshop 1
Room: Grays/Longs Peak

Speaker 7 of 7
Meghan Kerrisk Campbell, Alkahest, USA
A Therapeutic Human Plasma Fraction Enhances Cognitive Function in Aging and Neurodegenerative Disease through Multiple Mechanisms of Action

Monday, June 17 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Monday, June 17 | 5:00PM - 7:00PM
Transmission and Spread of Disease Pathology
Room: Grays/Longs Peak

Speaker 1 of 6
* Karen Hsiao Ashe, University of Minnesota, USA

Monday, June 17 | 5:00PM - 7:00PM
Transmission and Spread of Disease Pathology
Room: Grays/Longs Peak

Speaker 2 of 6
Xiaobo Mao, Johns Hopkins University, USA
The Mechanism of Pathological alpha-synuclein Transmission

Monday, June 17 | 5:00PM - 7:00PM
Transmission and Spread of Disease Pathology
Room: Grays/Longs Peak

Speaker 3 of 6
John Collinge, University College London, UK
Prion Neurodegeneration: Towards an Effective Treatment and its Relevance for Alzheimer’s Disease

Monday, June 17 | 5:00PM - 7:00PM
Transmission and Spread of Disease Pathology
Room: Grays/Longs Peak

Speaker 4 of 6
Karina Fog, H. Lundbeck A/S, Denmark
Alpha-Synuclein Antibodies as Therapeutics in Synucleinopathies – How Antibodies Affect Cellular Handling of Misfolded alpha-synuclein

Monday, June 17 | 5:00PM - 7:00PM
Transmission and Spread of Disease Pathology
Room: Grays/Longs Peak

Speaker 5 of 6
Amanda Engstrom, Emory University, USA
Short Talk: Pathological Tau Induces Neurodegeneration Through the Sequestration and Inhibition of LSD1 Function

Monday, June 17 | 5:00PM - 7:00PM
Transmission and Spread of Disease Pathology
Room: Grays/Longs Peak

Speaker 6 of 6
Xuyuan Kuang, Rutgers University, USA
Short Talk: Association of Transmissive PolyQ Aggregates with Lipid Vesicles and Its Implications in Mutant Huntingtin Seeding

Monday, June 17 | 5:00PM - 7:00PM
Astrocytes
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 1 of 4
Michael V. Sofroniew, University of California, Los Angeles, USA
Astrocyte Roles in Repair and Regeneration


Monday, June 17 | 5:00PM - 7:00PM
Astrocytes
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 2 of 4
* Jin-Moo Lee, Washington University, USA
Astrocytosis and Amyloid Plaque Pathogenesis


Monday, June 17 | 5:00PM - 7:00PM
Astrocytes
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 3 of 4
* Cagla Eroglu, Duke University Medical Center, USA
How do Glia Sculpt Synaptic Circuits?


Monday, June 17 | 5:00PM - 7:00PM
Astrocytes
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 4 of 4
Blanca Diaz Castro, University of Edinburgh, UK
Striatal Astrocytes: Identity, Form, Function and Roles in Huntington’s Disease


Monday, June 17 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Colorado Rockies Ballroom
No registration fees are used to fund alcohol served at this function.

Monday, June 17 | 7:30PM - 10:00PM
Poster Session 1
Room: Colorado Rockies Ballroom


Tuesday, June 18 | 7:30AM - 8:30AM
Breakfast
Room: Colorado Rockies Ballroom


Tuesday, June 18 | 8:30AM - 11:45AM
New Therapeutic Opportunities
Room: Grays/Longs Peak

Speaker 1 of 9
* Joseph W. Lewcock, Denali Therapeutics, USA

Tuesday, June 18 | 8:30AM - 11:45AM
New Therapeutic Opportunities
Room: Grays/Longs Peak

Speaker 2 of 9
Frank Rigo, Ionis Pharmaceuticals, USA
RNA Targeting Therapeutics for the Treatment of Neurodegenerative Diseases

Tuesday, June 18 | 8:30AM - 11:45AM
New Therapeutic Opportunities
Room: Grays/Longs Peak

Speaker 3 of 9
Eric J. Huang, University of California, San Francisco, USA
Microglia Toxicity and TDP-43 Proteinopathy in Neurodegeneration

Tuesday, June 18 | 8:30AM - 11:45AM
New Therapeutic Opportunities
Room: Grays/Longs Peak


Coffee Break

Tuesday, June 18 | 8:30AM - 11:45AM
New Therapeutic Opportunities
Room: Grays/Longs Peak

Speaker 5 of 9
Don W. Cleveland, University of California, San Diego, USA
Gene Silencing Therapy for Neurodegenerative Disease

Tuesday, June 18 | 8:30AM - 11:45AM
New Therapeutic Opportunities
Room: Grays/Longs Peak

Speaker 6 of 9
Li Gan, Weill Cornell Medicine, USA
Sex-Dimorphic Effects of Microglial Dysfunction in Neurodegeneration

Tuesday, June 18 | 8:30AM - 11:45AM
New Therapeutic Opportunities
Room: Grays/Longs Peak

Speaker 7 of 9
Dieter Willbold, Forschungszentrum Jülich, Germany
Short Talk: First Clinical Data of the First Anti-Prionic PRI-002 that is Orally Available, Reverts Cognition Deficits, and Decelerates Neurodegeneration in Transgenic AD Mouse Models

Tuesday, June 18 | 8:30AM - 11:45AM
New Therapeutic Opportunities
Room: Grays/Longs Peak

Speaker 8 of 9
Daniel Heinzer, University of Zurich, Switzerland
Short Talk: Whole Genome RNAi Screen Identifies Novel Regulators of PrPC as Potential Therapeutic Targets in Prion Diseases

Tuesday, June 18 | 8:30AM - 11:45AM
New Therapeutic Opportunities
Room: Grays/Longs Peak

Speaker 9 of 9
Alessandro Sette, La Jolla Institute for Immunology, USA
Short Talk: T Cell Reactivity to Tau and Alpha-Synuclein in PD

Tuesday, June 18 | 8:30AM - 11:45AM
Microglia and Innate Immunity
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 1 of 8
Dorothy Schafer, University of Massachusetts Medical School, USA
Targeting Microglia-Mediated Synapse Loss for Therapeutic Intervention in Multiple Sclerosis


Tuesday, June 18 | 8:30AM - 11:45AM
Microglia and Innate Immunity
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 2 of 8
Kim N. Green, University of California, Irvine, USA
Microglia Facilitate Plaque Development and Mediate the Downregulation of Synaptic Genes in Alzheimer’s Disease Mice


Tuesday, June 18 | 8:30AM - 11:45AM
Microglia and Innate Immunity
This session is from Neuroinflammation
Room: Quandary Peak


Coffee Break


Tuesday, June 18 | 8:30AM - 11:45AM
Microglia and Innate Immunity
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 4 of 8
* Anne Schaefer, Mount Sinai School of Medicine, USA
Epigenetic and Signaling Controlled Brain Region-Specific Microglia Functions


Tuesday, June 18 | 8:30AM - 11:45AM
Microglia and Innate Immunity
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 5 of 8
* Francisco J. Quintana, Harvard Medical School, USA
Molecular Control of Astrocyte Pathogenic Activities in MS


Tuesday, June 18 | 8:30AM - 11:45AM
Microglia and Innate Immunity
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 6 of 8
Serena Becchi, University of New South Wales, Australia
Short Talk: The Role of Microglia when Decision Making is Impaired by a High Fat and Sugar Diet in Rats


Tuesday, June 18 | 8:30AM - 11:45AM
Microglia and Innate Immunity
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 7 of 8
Manana Kutsia, Okinawa Institute of Science and Technology Graduate University, Japan
Short Talk: Importance of Microglia for Neural Tissue Regeneration in Zebrafish Model of Traumatic Brain Injury


Tuesday, June 18 | 8:30AM - 11:45AM
Microglia and Innate Immunity
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 8 of 8
Sandra Siegert, Institute of Science and Technology Austria, Austria
Short Talk: Sex Specific Microglia Response to Transient Reduction of Neuronal Activity


Tuesday, June 18 | 11:45AM - 5:00PM
On Own for Lunch


Tuesday, June 18 | 11:45AM - 1:00PM
Poster Setup
Room: Colorado Rockies Ballroom


Tuesday, June 18 | 1:00PM - 10:00PM
Poster Viewing
Room: Colorado Rockies Ballroom


Tuesday, June 18 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Tuesday, June 18 | 5:00PM - 7:00PM
Developing Effective Preclinical Disease Models
Room: Grays/Longs Peak

Speaker 1 of 5
* Valina L. Dawson, Johns Hopkins University School of Medicine, USA

Tuesday, June 18 | 5:00PM - 7:00PM
Developing Effective Preclinical Disease Models
Room: Grays/Longs Peak

Speaker 2 of 5
Martin Kampmann, University of California, San Francisco, USA
Elucidating Cellular Mechanisms and Therapeutic Strategies for Neurodegenerative Diseases with Multimodal CRISPR-based Genetic Screens in iPSC-Derived Neurons and Glia

Tuesday, June 18 | 5:00PM - 7:00PM
Developing Effective Preclinical Disease Models
Room: Grays/Longs Peak

Speaker 3 of 5
Elena Cattaneo, University of Milano, Italy
Organiod Models of Triple Repeat Diseases

Tuesday, June 18 | 5:00PM - 7:00PM
Developing Effective Preclinical Disease Models
Room: Grays/Longs Peak

Speaker 4 of 5
Fred H. Gage, The Salk Institute for Biological Studies, USA
iPSC to Study Repair and Neurodegeneration

Tuesday, June 18 | 5:00PM - 7:00PM
Developing Effective Preclinical Disease Models
Room: Grays/Longs Peak

Speaker 5 of 5
Zhuohao He, University of Pennsylvania, USA
Short Talk: Studying Tau Transmission in AD and FTLD Using Novel Mouse Models

Tuesday, June 18 | 5:00PM - 7:00PM
Blood Brain Barrier
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 1 of 5
Richard Daneman, University of California, San Diego, USA
Regulation of the Blood-Brain Barrier in Health and Disease


Tuesday, June 18 | 5:00PM - 7:00PM
Blood Brain Barrier
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 2 of 5
* Alexandre Prat, Université de Montréal, Canada
Influence of Cytokines on the Blood-Brain Barrier


Tuesday, June 18 | 5:00PM - 7:00PM
Blood Brain Barrier
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 3 of 5
* Eric V. Shusta, University of Wisconsin-Madison, USA
Modeling the Neurovascular Unit Using Human iPSCs


Tuesday, June 18 | 5:00PM - 7:00PM
Blood Brain Barrier
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 4 of 5
Sidar Aydin, University of Bern, Switzerland
Short Talk: Endothelial Antigen-Presentation Stops the Migration of CD8+ T Cells Across the Blood-Brain Barrier in Neuroinflammation


Tuesday, June 18 | 5:00PM - 7:00PM
Blood Brain Barrier
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 5 of 5
Matthew N. McCarroll, University of California, San Francisco, USA
Short Talk: An Inducible Zebrafish Model of Pineal Gland Ablation Reveals Dynamics of Neuronal Cell Death, Regeneration and Microgliosis in vivo


Tuesday, June 18 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Colorado Rockies Ballroom
No registration fees are used to fund alcohol served at this function.

Tuesday, June 18 | 7:30PM - 10:00PM
Poster Session 2
Room: Colorado Rockies Ballroom


Wednesday, June 19 | 7:30AM - 8:30AM
Breakfast
Room: Colorado Rockies Ballroom


Wednesday, June 19 | 8:30AM - 11:30AM
Translating Therapeutics for Neurodegeneration to the Clinic
Room: Grays/Longs Peak

Speaker 1 of 8
* Karina Fog, H. Lundbeck A/S, Denmark

Wednesday, June 19 | 8:30AM - 11:30AM
Translating Therapeutics for Neurodegeneration to the Clinic
Room: Grays/Longs Peak

Speaker 2 of 8
Joseph W. Lewcock, Denali Therapeutics, USA
Therapeutic Strategies Based on Human Genetics

Wednesday, June 19 | 8:30AM - 11:30AM
Translating Therapeutics for Neurodegeneration to the Clinic
Room: Grays/Longs Peak

Speaker 3 of 8
Matthew Kennedy, Merck Research Labs, USA
Discovery and Development of LRRK2 Inhibitors

Wednesday, June 19 | 8:30AM - 11:30AM
Translating Therapeutics for Neurodegeneration to the Clinic
Room: Grays/Longs Peak


Coffee Break

Wednesday, June 19 | 8:30AM - 11:30AM
Translating Therapeutics for Neurodegeneration to the Clinic
Room: Grays/Longs Peak

Speaker 5 of 8
David V. Hansen, Genentech, Inc., USA
Microglial Activation States in Alzheimer's Disease: Are You a (Wo)man or a Mouse?

Wednesday, June 19 | 8:30AM - 11:30AM
Translating Therapeutics for Neurodegeneration to the Clinic
Room: Grays/Longs Peak

Speaker 6 of 8
Jeffrey L. Cleland, Orpheris, Inc., USA
Short Talk: OP-101: Human Safety and Pharmacokinetics of a Microglia-targeted Systemic Therapy for Neuroinflammation

Wednesday, June 19 | 8:30AM - 11:30AM
Translating Therapeutics for Neurodegeneration to the Clinic
Room: Grays/Longs Peak

Speaker 7 of 8
Anna Ettorre, 4D Pharma Research Ltd., UK
Short Talk: From Screening to Pre-Clinical Efficacy of Microbiome-Derived Bacterial Strains that Modulate Neuroinflammatory and Neurodegenerative Processes in Parkinson's Disease

Wednesday, June 19 | 8:30AM - 11:30AM
Translating Therapeutics for Neurodegeneration to the Clinic
Room: Grays/Longs Peak

Speaker 8 of 8
Garrett S. Gibbons, University of Pennsylvania, USA
Short Talk: Conformation-Selective Tau Monoclonal Antibodies as Immunotherapy Candidates for Alzheimer's Disease (AD)
and Frontotemporal Lobar Degeneration-tau (FTLD-tau)


Wednesday, June 19 | 8:30AM - 11:45AM
Glymphatics and Lymphatics
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 1 of 8
* Kari K. Alitalo, University of Helsinki, Finland
CNS Lymphatics


Wednesday, June 19 | 8:30AM - 11:45AM
Glymphatics and Lymphatics
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 2 of 8
Iben Lundgaard, University of Lund, Sweden
Glymphatics


Wednesday, June 19 | 8:30AM - 11:45AM
Glymphatics and Lymphatics
This session is from Neuroinflammation
Room: Quandary Peak


Coffee Break


Wednesday, June 19 | 8:30AM - 11:45AM
Glymphatics and Lymphatics
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 4 of 8
Maria Lehtinen, Harvard Medical School, USA
Orchestration of Embryonic Brain Development by the Choroid Plexus


Wednesday, June 19 | 8:30AM - 11:45AM
Glymphatics and Lymphatics
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 5 of 8
* Julie Siegenthaler, University of Colorado Denver, USA
Meningeal Fibroblast Identity and Function: New Insights from scRNA-Sequencing


Wednesday, June 19 | 8:30AM - 11:45AM
Glymphatics and Lymphatics
This session is from Neuroinflammation
Room: Quandary Peak

Speaker 6 of 8
Percy Griffin, Washington University in St. Louis, USA
Short Talk: Circadian Regulation of Neuroinflammation and Neurodegeneration by Rev-Erba


No content found

No content found

No content found